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ABSTRACT
Adenosine-to-Inosine (A-to-I) RNA editing is a
post-transcriptional mechanism, evolved to diver-
sify the transcriptome in metazoa. In addition to
wide-spread editing in non-coding regions protein
recoding by RNA editing allows for fine tuning of
protein function. Functional consequences are only
known for some editing sites and the combinatorial
effect between multiple sites (functional epistasis) is
currently unclear. Similarly, the interplay between
RNA editing and splicing, which impacts on
post-transcriptional gene regulation, has not been
resolved. Here, we describe a versatile antisense
approach, which will aid resolving these open ques-
tions. We have developed and characterized
morpholino oligos targeting the most efficiently
edited site—the AMPA receptor GluA2 Q/R site.
We show that inhibition of editing closely correlates
with intronic editing efficiency, which is linked to
splicing efficiency. In addition to providing a versa-
tile tool our data underscore the unique efficiency of
a physiologically pivotal editing site.
INTRODUCTION
Adenosine-to-Inosine (A-to-I) RNA editing, the post-
transcriptional conversion of single nucleotides in pre-
mRNA, is a unique mechanism for protein diversification
particularly in the nervous system (1–3). This process
requires RNA secondary structures within primary
mRNA transcripts that are recognized by adenosine
deaminases [adenosine deaminases acting on RNA
(ADARs)], which catalyze the conversion of adenosine
to inosine. During translation of edited coding sequences,
inosine is recognized as guanosine thus resulting in a
change to the RNA codon and often the protein
sequence (4,5). ADARs are essential, their deletion
results in premature death in vertebrates and to severe
nervous system dysfunction in invertebrates (2). In
addition to fine-tuning function of central signaling mol-
ecules RNA editing abundantly targets non-transcribed
regions, particularly in vertebrates and thereby regulates
RNA metabolism (1).
The first A-to-I site to be described was the Q/R site in
AMPA-type glutamate receptors (AMPARs) (6): cation
channels mediating the bulk of fast excitatory neurotrans-
mission in vertebrate brains (7). This editing site locates to
the channel pore where it determines ion flux and channel
assembly (6,8). Edited varieties render the channel Ca2+
impermeable, and by disfavoring assembly of edited
homotetrameric GluA2 the formation of AMPAR
heteromers is enabled. GluA2 Q/R editing is essential
for survival, the site is edited to >99% (6). Reduced
GluA2 Q/R editing in gene-targeted mice results in
severe seizures and premature death, which is linked to
altered Ca2+ permeability through AMPARs (9,10). The
Q/R site is exclusively edited by the editase Adar2; deletion
of the Adar2 locus resembles the severe phenotype of
editing-deficient Gria2 alleles, and is rescued by expression
of a Q/R-edited Gria2 allele (in the Adar2-/- background)
(11). Moreover, underediting of the Q/R site is associated
with a variety of diseases in humans, such as epilepsy
ischemia and amyolateral sclerosis (ALS) (2,12,13). ALS
has been studied in some detail, where it appears that
reduced expression of ADAR2 are linked to reduced
Q/R editing resulting in motor neuron degeneration (13).
Together, these findings highlight the unique nature of the
GluA2 Q/R site, with efficient editing being pivotal to
survival of the organism. The question of why this
critical position ‘relies’ on editing, rather than being
hardwired into the genome, remains a mystery (14).
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High-throughput approaches increasingly demonstrate
a prominent role for A-to-I editing in development, me-
tabolism and in disease (15). Contrasting with the rapid
pace of these technical developments is a good under-
standing of the biology of individual editing sites.
Antisense probes provide unique versatility to interfere
with RNA-based processes including splicing and transla-
tion, where this approach has provided key insights. In the
context of editing, a steric block antisense oligonucleotide
(oligo) could be designed to hybridize to the editing site
complementary sequence (ECS) and/or double stranded
RNA binding sites of ADARs. As the secondary structure
is essential for Adar binding, strand invasion and hybrid-
ization of the antisense oligo would inhibit A-to-I editing
(Figure 2). This substrate-targeted approach could permit
site-specific manipulation of endogenous editing sites. A
widely used antisense oligo for steric antisense applica-
tions is the morpholino oligo. Morpholinos have been
used extensively to modify pre-mRNA splicing, block
mRNA translation and inhibit miRNA maturation or
activity (16,17). Importantly given the duplex structure
of the Q/R editing substrate, potent antisense activity of
morpholinos has been demonstrated on highly structured
RNA targets (18–20).
Here, we first provide an in-depth characterization and
evolutionary relationships of the GluA2 AMPAR Q/R
editing substrate. We go on to describe experiments that
provide a proof-of-principle for substrate-targeted com-
petitive inhibition via antisense probes. We then use the
antisense strategy to characterize the link between Q/R
editing and intron 11 splicing and demonstrate the
remarkable resilience of the GluA2 Q/R site. This
approach will facilitate an in-depth characterization of in-
dividual metazoan A-to-I RNA editing sites.
MATERIALS AND METHODS
Bioinformatics
The imperfect inverted repeat containing the Q/R site was
identified from the rat Gria2 gene sequence (exons 11–12)
using the EINVERTED application of a locally installed
European Molecular Biology Open Software Suite
(EMBOSS) [Version 6.0.1; (21) interfaced with Jemboss
Graphical User Interface (GUI) (Version 1.5)] (22). The
imperfect inverted repeat of rat along with some flanking
sequence was used as a Basic Local Alignment Search
Tool (BLAST) or BLAST-Like Alignment Tool (BLAT)
search query to indentify homologs from the online
Ensembl and Pre-Ensembl vertebrate assemblies (23–25).
Likewise, shark sequence was retrieved from the whole
genome shotgun sequence database on the Institute of
Molecular and Cell Biology server (26). The sequence co-
ordinates and associated information are documented in
Supplementary Table S1. Sequences were aligned using
Multiple Alignment based on Fast Fourier Transform
(MAFFT) by iterative refinement with pairwise alignment
information [L-INS-i; Version 6.903; (27)]. Sequence simi-
larity was calculated and data output from the
PLOTCON application in EMBOSS using the EDNA
scoring matrix and a window size of 1. The g-centroid
consensus structure was predicted from the alignment
using CentroidAlifold with a default inference engine
[Version 0.0.9; (28)]. The common structure was
superimposed onto the rat GluA2 pre-mRNA sequence
and visualized with Visualization Applet for RNA
(VARNA) [Version 3.8; (29)]. The posteriors were used
to plot the probabilities of base pairs shown in the con-
sensus structure.
Cell culture
HEK-293T, HeLa and SH-SY5Y cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (contain-
ing glutamax 1; GIBCO) supplemented with 10% heat-
inactivated (56! C, 30min) fetal bovine serum (FBS) and
penicillin/streptamycin (Pen/Strep). MIN-6 cells were
cultured in DMEM (GIBCO) containing 10% heat-
inactivated FBS and (in mM): dextrose (25), L-Glutamine
(1), b-mercaptoethanol (0.0715) and Pen/Strep. Plasmid
DNA constructs were transfected into Hek 293T and
HeLa cells using Effectene (Qiagen) and Lipofectamine
2000 (Invitrogen), respectively. Morpholinos were
delivered into all cell lines (except MIN-6) using Endo-
Porter (Gene Tools) (30). Transfections into MIN-6 cells
were by electroporation using solution kit R and program
T-027 (Amaxa).
Molecular biology
Morpholino 25-mer oligos with a 30-carboxyfluorescein
end modification were ordered from Genetools, LLC
(www.gene-tools.com) Morpholino sequences are
detailed in the Supplementary Table S2. The standard
negative control morpholino (control) is expected to not
cause effect as it only shows complementarity to an
aberrant 50 splice site created by a point mutation in the
second intron of the b-globin gene (IVS2705) in a subset of
human b-thalassemia patients (31). DNA and RNA were
extracted from cells and tissues by the acid guanidinium
thiocyanate-phenol-chloroform procedure, using Trizol
according to the manufacturers’ instructions (15596,
Invitrogen). For RNA, the pellet was resuspended in
buffer (in mM): Tris-Cl (40), NaCl (10), CaCl2 (1),
MgCl2 (6) supplemented with 0.5U/ml human placental
ribonuclease inhibitor (N2111, Promega) and 0.1U/ml
RNase-free DNase I (Roche). DNA digestion proceeded
at 37! C for "0.5 h. Samples were diluted to 0.5ml with
Rnase-free water (Ambion) and RNA was repurified by
mixing with one volume of 5:1 acid phenol:chloroform
(pH 4.3) and spinning down at 10 000g for 5min at
room temperature in a bench top centrifuge. The
aqueous supernatant was transferred to a new
microcentrifuge tube and residual phenol was removed
by mixing with one volume of chloroform and spinning
down as before. RNA was precipitated with 20 mg
glycogen, 0.3M sodium acetate (pH 5.2) and one
volume of isopropanol at room temperature and pelleted
at 10 000g for 10min at 4! C or room temperature. The
RNA pellet was washed with 75% ethanol, air-dried and
resuspended in Rnase-free water (Ambion). Ribosomal
RNA integrity was assessed by native agarose gel electro-
phoresis and cDNA synthesis was carried out
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using random hexamers (Invitrogen) and Avian
Myeoloblastosis Virus reverse transcriptase according to
the Gu¨bler and Hoffman procedure in the manufacturers
instructions (SuperRT, HT Biotechnology). PCR
amplicons from cDNA templates were subjected to restric-
tion digests with either BbvI (GCAGC) or TauI (GCGGC
), or products were sequenced with the Sanger method and
the relative peaks of nucleotides at the position of the
editing sites were quantified using PeakPicker (32)
or BioEdit software (http://www.mbio.ncsu.edu/bioedit/
bioedit.html).
For experiments with reporter constructs, PCR ampli-
fication of the minigene transcript was achieved from the
cDNA of cell RNA extract. In addition to the use of
DNase I digestion of RNA samples, contamination of
plasmid DNA was minimized by amplification using
primers spanning efficiently spliced introns native to the
pCI-neo and pET01 vectors, which expressed the GluA2
Q/R and R/G site minigenes, respectively. The Q/R site
minigene was a cloned BglII–XbaI fragment of the rat
Gria2 gene encompassing the 30 half of exon 11 and the
50-end of intron 11–12. The R/G site minigene was a
cloned fragment of the mouse Gria2 gene encompassing
exons 13–16.
RESULTS
Properties of the Q/R substrate
The Q/R site is located near the end of exon 11 of the Gria2
locus (Figure 1A). Here, it exists within an imperfect
inverted repeat, which extends into intron 11–12 and
forms a complex pre-mRNA secondary structure subject
to deamination by Adar2 (Figure 1A: inset) (33). To inves-
tigate attributes of the Q/R site substrate underlying its
efficient editing we used a bioinformatics approach to
examine genetic variations that are permissive for editing
in situ. For this, we focused on genome sequencing projects
from 50 vertebrate species with diploid genomes, including
1 cartilaginous fish (Chondrichtyes), 1 amphibian
(Amphibia), 2 turtles (Anapsida), 1 scaled reptile and 5
birds (Diapsida), 1 egg layingmammal (Prototheria), 2mar-
supials (Metatheria) and 37 placental mammals (Eutheria)
(Supplementary Table S1). Polyploidy in bony, ray-finned
fish (Actinopterygii) had introduced a second GluA2
subunit genomically encoding an arginine at the Q/R site
position (gria2b), which could reduce evolutionary
pressure to maintain high A-to-I editing efficiency in the
primary subunit (gria2a) and so were not included. Aligned
DNA sequences of the imperfect inverted repeat indicated
that sequence similarity was high in the 30-end of the exon
and the splice donor site, and in specific regions of the im-
perfect inverted repeat. In contrast, the region separating
the repeats was poorly conserved and of variable length,
consistent with earlier deletion experiments demonstrating
it to be dispensable for in vitro editing (Figure 1A and B)
(33–35).
Our phylogenetic sequence analysis was used to predict
the consensus secondary structure and identify the funda-
mental structural features required for the essential,
high-efficiency editing reaction at the Q/R site
(Figure 1A). Calculated base pairing probabilities were
highest around the Q/R and intronic editing sites (>0.8).
Closer inspection of the Q/R substrate revealed that most
sequence variation that does occur comprises consistent
mutations that do not alter basepairing (e.g. AU to GU;
including a genomically encoded guanine at the+4 editing
site; Figure 1C: green), or a mutation that maintains a
mismatch position (GA to AA; Figure 1C: blue) to
conserve overall RNA secondary structure. In contrast,
a small cluster of mutations in the triplet guanosine
(+302 to +304) appears mostly to disrupt base pairing
(Figure 1C). Consistent with this finding, introducing an
N2-benzyl modification into the minor groove at the
guanosine +303 position does not impact on in vitro
editing at the Q/R site (36). Together, these data reveal
novel aspects of this unique editing substrate and highlight
specific regions of double strandedness critical for Q/R
editing, thus providing a guide for antisense target design.
Antisense inhibition of an exogenous Q/R editing
reporter system
The double stranded nature of A-to-I editing sites implies
a substrate requirement for editing that could be targeted
by competitive inhibition: hybridization of a steric anti-
sense probe to the ECS to disrupt Adar2 binding and de-
amination. Potent steric antisense activity of morpholino
oligos has been demonstrated on highly structured RNA
targets (18–20). Given the extensive duplex structure of
the Q/R editing substrate this site was chosen as a poof-
of-principle target. A 25-mer morpholino was designed to
hybridize to the entire Q/R site ECS (+315 to+324), the
binding site of dsRBD1 (+307 to+317) and five unstruc-
tured base positions outside the structured RNA to assist
in strand invasion of the antisense oligo (Figure 1A:
outlined in green; Figure 2; Supplementary Table S2).
To test the antisense approach, we initially used an ex-
ogenous reporter system (33–35,37) (Figure 3A: top). This
constitutes a fragment of the rat GluA2 gene, encompass-
ing the 30 half of exon 11 and !0.5 kb of the proximal
portion of the proceeding intron (33). The reporter was
transfected into HeLa cells, which have been shown previ-
ously to have some A-to-I RNA editing activity (34) and
respond well to the Endo-porter morpholino delivery
reagent (30). Amplicons of the minigene reporter transcript
showed both adenine, and to a lesser extent, guanine at the
editing site in the chromatograms obtained by Sanger
sequencing (Figure 3B). In addition, digestion with BbvI
(GCAGC) restriction enzyme gave two detectable bands
corresponding to the predicted fragment sizes (Figure
3C). In contrast, a construct with the edited residue
genomically encoded showed only guanine and a !ECS
construct exhibited only an adenine at the editing site
(Figure 3A–C). These results validate the test system and
confirm the essential role of the ECS in Q/R editing.
Antisense oligo (10mM) delivered into reporter-
expressing HeLa cells resulted in significantly inhibition
of Q/R editing compared with vehicle controls
(Figure 3D). A dose–response experiment provided a
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50% inhibitory concentration (IC50) of !1.9 mM
(Figure 3E and F). In contrast, editing was not affected
by any tested concentrations of a standard negative control
oligo (Supplementary Table S2; Figure 3E and F) (http://
www.gene-tools.com/node/23#standardcontrols).
Together, these experiments indicate that Q/R editing of a
minigene reporter can indeed be effectively perturbed
using a substrate-targeted antisense oligo. Furthermore,
we could demonstrate that this effect was sequence and
editing site specific (Supplementary Figure S1A and S2;
see also next section). The ability and specificity of the
antisense to inhibit Q/R editing of endogenous GluA2
was examined next.
Specific steric antisense inhibition of the endogenous
Q/R editing substrate
The neuroblastoma cell line SH-SY5Y expresses GluA2
endogenously, which is edited by Adar2 (38).
Morpholinos were delivered over a 16–24 h period
before assaying the editing state of the Q/R site. In
Figure 1. Phylogenetic analysis of the Q/R site substrate. (A) The predicted common secondary structure (g-centroid estimator) of the GluA2
pre-mRNA encompassing the Q/R site for 50 vertebrate species (Supplementary Table S1) mapped onto the rat sequence. Base pairs are
rendered according to the Leontis/Westhof nomenclature. The splice donor site and editing sites are annotated in violet and red, respectively.
Editing site designations and sequence numbering are as published by the Seeburg laboratory (33): the base position numbering corresponds to that
of the aligned mouse sequence with reference to the Q/R site (position=0). Lilac highlight=exon sequence; salmon highlight=Q/R ECS; dotted
green line annotation=antisense morpholino target sequence; grey asterisk=variable region (lacking sequence similarity or a common structure).
Roman numerals I–III label prominent, highly conserved helical elements [see (B)]. Inset: Imperfect inverted repeat illustrated on a scaled schematic
of the rat Gria2 gene fragment spanning exons 11–12. (B) Line plots summarizing the data relating to (A). Primary axis is for vertebrate sequence
similarity (green) and secondary axis is for probabilities of the base pairs shown in the predicted consensus structure (A). Only data for base positions
aligned to the rodent sequence are shown (i.e. alignment gaps were deleted). The variable region separating the imperfect inverted repeats showed
little to no sequence or structural conservation and therefore was omitted from the plot. A linearized schematic of the rat GluA2 pre-mRNA features
is shown above the plot to annotate the base positions. (C) Detailed characterization of the minimal Q/R site editing substrate across vertebrates.
The mapped Adar2 double-stranded RNA binding domain I (dsRBDI) binding site spans the helical element outlined with a dotted grey line.
Vertebrate species that deviate from the common sequences of either strand are shown. The sequence variation is color coded: green font indicates
that canonical RNA base pairing is maintained; blue font indicates that a mismatch is maintained and red indicates a change in RNA secondary
structure. The more recently available sequences for diploid bony fish species coelacanth and spotted gar were not included in the original alignment
used to create (A) and (B). However, their inclusion gives a similar consensus structure when mapped onto the rat sequence.
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vehicle controls, GluA2 mRNA was !85% edited at the
Q/R site. Titration of the antisense oligo caused a striking,
dose-dependent switch in the editing state of endogenous
GluA2 mRNA (Figure 5A: green line). At the highest dose
tested (20mM), the antisense resulted in !80% drop in the
relative quantity of Q/R edited mRNA compared with
vehicle delivery control or to the standard negative
control oligo (Figure 4A and B). To control for the pos-
sibility that differences in solubility could result in varying
extents of delivery between antisense and control oligos we
used an oligo with equivalent base content to the anti-
sense, but with inverted sequence (Supplementary Table
S2). As with the standard negative control oligo, this
invert morpholino showed no inhibition (Figure 4A and
B). In addition, five mismatches distributed along the
length of the antisense sequence (with minimum change
to the GC content; Supplementary Table S2) completely
abolished the ability of the oligo to inhibit Q/R editing,
indicating that sequence specificity was maintained
(Figure 4A and B). Furthermore, the antisense was not
associated with inhibition of editing in endogenously ex-
pressed 5-HT2CR mRNA indicating that a general effect
on A-to-I editing is unlikely with up to 10" mM of anti-
sense morpholino (Supplementary Figure S1B). We also
obtained the same result for a similar series of control
experiments using the exogenous reporter system in
HeLa cells (Supplementary Figure S1A and S2).
If the morpholinos are operating via a steric mechanism,
the above results should be reproducible using a different
backbone chemistry, which similarly does not induce
RNase-H cleavage or trigger RNA interference.
Accordingly, we could reproduce inhibition of the Q/R
site using an alternative antisense approach: oligos
comprised of 20-O-Methyl RNA/locked nucleic acid
(20-O-Me/LNA) mixmers (39,40) also interfered with Q/
R editing, albeit with reduced efficacy (Supplementary
Figure S3).
The dramatic effect of competitive inhibition by
morpholinos on the high editing levels of endogenous
GluA2 mRNA (!85%) was surprising given that
efficacy of a competitive inhibitor would be expected to
be lower when basal levels of editing (and thus competing
levels of Adar2) are higher. To understand this better we
examined editing in the endogenous GluA2 pre-mRNA of
SH-SY5Y. Consistent with a recent report (38), the editing
state of the Q/R site in SH-SY5Y under control conditions
was !3-fold lower for pre-mRNA than for spliced mRNA
(Figure 4C). Analyzing the antisense dose–response data
for pre-mRNA indicated that the IC50 was very similar to
that of the corresponding mRNA (1.8 versus 2.8mM:
pre-mRNA versus mRNA; Figure 5A) suggesting that
antisense efficacy was comparable for the two RNA popu-
lations. The relationship between editing and splicing was
examined next.
Coupling of intronic hotspot 2 and splicing to Q/R site
substrate integrity
The data above uncovered a disparity between Q/R
editing before and after splicing, which is consistent with
earlier reports describing greater splicing efficiency for the
Q/R-edited GluA2 pre-mRNA (11,41,42). The antisense
approach provided an opportunity to test this relationship
further. We plotted dose–response data for ratios of
editing in mRNA against those of pre-mRNA; the slope
of the resulting plot providing the relative splicing effi-
ciency (Supplementary Figure S6). The data were signifi-
cantly correlated (r=0.86, P< 0.0001, Spearman’s rank)
and were fit well by a linear function (R2=0.8) with a
slope corresponding to !3.8 times more efficient splicing
of edited pre-mRNA (Figure 5B). It has been
demonstrated recently that the combination of editing at
the Q/R site and at intronic hotspot 2 (position+262) is
responsible for more efficient splicing of edited GluA2
pre-mRNA (42). Therefore, we analyzed the extent of
editing at the intronic hotspots (Figure 5C). Given that
these lie in an independent helical element (Figure 1A:
helix II) to the Q/R site (Figure 1A: helix I) and antisense
target we were surprised to find that hotspot 2 editing (in
particular +262) was inhibited by the antisense as effi-
ciently as the Q/R site (Figure 5D). Moreover, the
editing at both sites was well-correlated (r=0.81,
P< 0.01; Spearman’s rank; Figure 5E). Therefore, there
appears to be a direct coupling of the Q/R site and hotspot
2 that maintains preferential splicing of the Q/R-edited
GluA2 pre-mRNA (42).
Editing-coupled splicing efficiency and high basal editing
activity safeguard the Q/R site
The low level of editing at the Q/R site of GluA2
pre-mRNA in SH-SY5Y is unlike that in brain, where it
often exceeds 95% (Figure 6A; Supplementary Table S3).
Similarly, MIN-6, a b-pancreatic cell line, expresses
GluA2 with near 100% editing of the Q/R site in GluA2
pre-mRNA (Figure 6A; Supplementary Table S3). In
Figure 2. A steric antisense strategy to inhibit an A-to-I editing site.
The substrate-targeted strategy is demonstrated for A-to-I editing on a
simplified schematic of the GluA2 pre-mRNA Q/R site (see text).
Arg=arginine; Gln=glutamine; Adar2=adenosine deaminase
acting on RNA2; CAG is the sequence of the arginine triplet codon
targeted by Adar2 for enzymatic deamination to CIG (read as CGG,
the glutamine triplet codon).
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addition, intronic pre-mRNA editing hotspots and the
R/G editing site of GluA2 mRNA are processed to
levels mirroring neural tissue (Supplementary Table S3).
Therefore, we used MIN-6 as a tractable cell system for
testing the ability of the antisense to perturb Q/R editing
in the background of more neuron-like levels of editing
activity. The extent of inhibition by morpholinos was
compared with inhibition via dominant negative Adar2
mutants. In particular, we over-expressed catalytically
inactive (E396A) and dominant negative (EAA) forms of
Adar2 fusion protein with enhanced green fluorescent
protein (EGFP) (Figure 6B). As MIN-6 cells were irre-
sponsive to the delivery vehicle used for the other cell
lines, we delivered morpholinos using electroporation
and assayed the editing state of GluA2 pre-mRNA.
MIN-6 cells were electroporated with the
Adar2 mutants, allowed to express for 3 days, then
EGFP-positive cells were collected by fluorescence-
activated cell sorting (Figure 6C). The E396A mutant
of Drosophila Adar has been shown previously to inhibit
editing up to 60% for some targets in vivo (43). For the Q/
R site, we observe only a modest 5% drop in Q/R
pre-mRNA editing compared to EGFP alone (Figure
6C). In the dominant negative construct, mutations of
key lysine residues (KKXXK) in both dsRBDs to
EAXXA has been proposed to act in a dominant
negative fashion by sequestering endogenous Adar2 into
non-functional heterodimers (44); we detected a !3.5-fold
greater inhibition by this mutant compared with E396A.
However, overall levels of pre-mRNA editing were still as
high as 83%, reflecting the unique editing efficiency of the
AMPAR Q/R site. Similarly, the antisense oligo reduced
pre-mRNA editing to 86%. To confirm that the results
were not due to one of the Gria2 alleles having a
Figure 3. The antisense strategy inhibits editing of a Q/R site minigene reporter. (A) Minigene reporter constructs for Q/R editing (top). Note the
efficiently spliced vector-derived intron (VDI) located 50 of the insert used to assist selective amplification of cDNA). The KpnI restriction site was
used to create the !ECS mutant (middle). As a positive control for detection of edited transcripts, we also created a construct with a genomically
encoded QR site (bottom). pA+=polyadenylation signal; pCMV=cytomegalovirus promoter. (B) Sequence chromatograms of RT-PCR amplicons
for each of the corresponding constructs expressed in HeLa cells. (C) The qualitative results obtained in (B) by sequencing are supported by specific
enzyme digest. Restriction enzyme (BbvI) digests of RT-PCR amplicons for each construct were loaded on an agarose gel (3%), which was then
post-stained with ethidium bromide. The image shown was inverted for clarity. A constitutive BbvI restriction site in the amplicon incorporated by
one of the primers served as a control for digestion. N=non-digested fragment; R=edited digestion fragment; Q=unedited digestion fragment.
Note that for the WT construct the uncut edited fragment appears more intense than the cut unedited fragment. This is in contrast to what is seen
with the same sample by Sanger sequencing. This is likely due to the fact that the level of ethidium bromide staining is a function of the size and the
abundance of the DNA fragment. In addition, it is possible that heteroduplexes formed in PCR are not cut effectively by this restriction enzyme. For
these reasons we have quantified editing from sequence chromatograms. (D) Antisense morpholino provided robust and significant inhibition of Q/R
editing of the reporter minigene. Bar graph showing the percentage editing of the reporter minigene with vehicle and with antisense morpholino. The
morpholino delivery vehicle was Endo-Porter. The sample size was 3 - 4 transfections. Error bars represent SEM. ***P< 0.001 (Student’s two-tailed
unpaired t-test with Welch’s correction). (E) Sequence chromatograms of RT-PCR amplicons derived from HeLa cells expressing the reporter
minigene and treated with different doses of standard control morpholino and antisense morpholino. The morpholino delivery vehicle was
Endo-Porter (Gene-Tools). (F) The peak heights of the sequence chromatograms in (E) are quantified (see ‘Materials and Methods’ section) and
plotted as percentage editing against morpholino concentration on a logarithmic scale. The 10 mM concentration for the control morpholino was not
carried out in this experiment. The data points for the antisense treatment were fit with sigmoidal curve using the equation: d+A/(1+exp((x"x0)/c)).
The IC50 was 1.9 mM.
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genomically encoded guanine at the Q/R editing position
(as occurs in the Gria2! paralogue in Teleost fish) we
examined the editing state of the genomic DNA.
Restriction digest with TauI (GCGGC) revealed
complete editing of pre-mRNA but only one band (cor-
responding to the unedited sequence: GCAGC) in
genomic DNA (Figure 6E), which ruled out this possibil-
ity. To account for GluA2 mRNA turnover in MIN-6 cells
we tested a range of harvesting time points post-
electroporation for the antisense oligo and found that
the largest drop (!45%) in Q/R editing of GluA2
pre-mRNA at the earliest time point (at 12 h), and a
gradual increase in editing over time, which likely
reflects dilution of the antisense oligo during cell divisions
(Figure 6D). The changes in Q/R editing of pre-mRNA
was accompanied by only small changes in editing of the
spliced mRNA (Figure 6D).
DISCUSSION
Here, we describe a strategy to selectively target specific
A-to-I editing sites for inhibition. Steric antisense
morpholinos designed to hybridize to the ECS of the
GluA2 Q/R site substrate specifically and effectively per-
turbed editing at this site in the background of lower
A-to-I editing activity, which is commonly seen with
most other A-to-I editing targets. In addition, the anti-
sense approach revealed a tight coupling of intronic
hotspot 2 to the Q/R site, which likely ensures more effi-
cient splicing of Q/R edited pre-mRNA. This ‘safe-guard’,
potentially unique to the Q/R site (Supplementary Figure
S4), contributes to the difficulty in perturbing Q/R editing
in the background of high-editing activity. This novel anti-
sense approach could be used to identify currently unex-
plored functions of select A-to-I editing sites.
We used morpholino backbone chemistry to make steric
block antisense oligos. Unmodified DNA and RNA oligos
are rapidly degraded in biological systems by enzymatic
cleavage of the phosphodiester bond (Supplementary
Figure S3B, R=O") and are prone to hydrolysis due to
the presence of a hydroxyl group on the 20-carbon of the
ribose sugar (Supplementary Figure S3B, X=OH). Some
leading backbone modifications for steric antisense appli-
cations include peptide nucleic acids, morpholinos and 20-
O-methyl RNA/LNA mixmers. For example,
morpholinos are widely used to modify pre-mRNA
splicing, block mRNA translation and inhibit miRNA
maturation or activity (16,17) and have been used in
several model organisms, such as sea urchins, zebrafish,
frogs, chicks and mice (45). We add another application to
this list: steric antisense inhibition of RNA editing. The
application of new antisense delivery systems [e.g. Tat
peptides (39,40)] with the current strategy will facilitate
evaluation of editing sites in vivo.
In our application of the antisense tool, our data empha-
sizes the robust nature of this functionally critical A-to-I
Figure 4. Potent inhibition of the endogenous Q/R site editing in SH-SY5Y cells. (A) Effective and sequence-specific inhibition of Q/R editing in
mRNA of SH-SY5Y. Sequence chromatograms for SH-SY5Y cells transfected with morpholinos delivered at 20 mM using Endo-Porter vehicle.
Sequence specificity was maintained in mismatch control at this relatively high concentration. Asterisk indicates the adenine peak in the antisense
morpholino sample trace. (B) The inhibition of Q/R editing in SH-SY5Y mRNA was highly significant. Morpholino concentrations were 20 mM.
Error bars represent SEM. The sample size for each treatment was 3. **P< 0.01, n.s.=not significant (P< 0.0001, one-way ANOVA with Dunnett’s
post-test comparison: morpholino versus vehicle control). (C) Graph illustrating the percentage Q/R editing of GluA2 pre-mRNA and mRNA in
control dishes of SH-SY5Y. The 3-fold difference is highly significant (two-tailed t-test). ***P< 0.001.
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editing substrate. Intact preferential splicing of edited
pre-mRNA combined with high-editing activity will
make transient fluctuations of Adar2 unlikely to lead to
significant changes in editing status of spliced (protein
coding) transcript (42). This is supported by our experi-
ments using siRNAs to knockdown Adar2 in cultured
neurons (Supplementary Figure S5). Recently, it was
shown that increased splicing efficiency requires edited pos-
itions at both the Q/R site and hotspot 2 (43). Our antisense
approach provides evidence for a coupling between hotspot
2 and Q/R substrate integrity. Consistent with the essential
requirement for editing the Q/R site, we show that the
hotspot 2 sequence and structure of the associated helical
element (Figure 1A: helix II) is almost as well-conserved as
the Q/R site substrate itself (Figure 1A: helix I; Figure 1B).
This observation for coupling between the editing sites is
also supported by earlier ECS mutagenesis experiments
(33). The absence of obvious coupling to the+60 site on
the complementary strand of hotspot 2 is not
surprising given that it is almost exclusively an Adar1
target (11).
Positive and negative coupling between relatively
distant editing sites and RNA secondary structures has
been shown recently for the Adar2, 5-HT2CR, GluK2
and Gabra3 substrates (47,48). One possible explanation
for the positive coupling observed in GluA2 could be as
follows: Adar2 binds the Q/R substrate and dimerizes
(44,45), the second subunit then binds and edits hotspot
2. Such avidity would be consistent with the high levels of
pre-mRNA editing typically observed for the Q/R site
compared to some other A-to-I editing sites. Consistent
with this in vitro editing of a minimal Q/R substrate (like
the one shown in Figure 1C) is less efficient than that of
the complete pre-mRNA in vivo (36). However, in the
absence of structural information, proof for such a mech-
anism remains unexplored.
Figure 5. Coupling of inhibition at the Q/R site and editing at intronic hotspot 2. (A) Dose-dependent inhibition of Q/R editing of SH-SY5Y GluA2
pre-mRNA (blue) and mRNA (green). Error bars represent SEM. The data points were fit with the equation a+b*ln(x+c). The IC50 values for
pre-mRNA and mRNA were 1.8 and 2.8 mM, respectively. The inset shows the data normalized to vehicle control and plot against concentration on
a logarithmic scale. (B) Preferential splicing of the Q/R-edited pre-mRNA probed using the antisense. The editing ratios from dose–response
experiments were corrected for non-linearities of mixed sequence peaks using standard curves created with plasmid mixtures and the corrected
data were plot on a scatter graph. The data points were fit by least squares linear regression through the origin (R2=0.80) and correlation tested
with Spearman’s rank. The slope corresponds to the fold difference in splicing efficiency for edited pre-mRNA compared with unedited pre-mRNA
(Supplementary Figure S6). The inset shows how the data and the fit look when editing is expressed as percentages; the fit becomes hyperbolic. Note
that the slope of the relationship decreases as the % pre-mRNA editing increases. (C) Quantification at ‘editing’ ratios at all adenine positions in the
imperfect inverted repeat upto position +305. Black line is vehicle control, red line is antisense. The exon–intron structure is illustrated above the
plot. The difference in peak heights is plot below (blue line). (D) A bar graph showing editing at the Q/R site and intronic editing hotspot 2 (position
+262) in GluA2 pre-mRNA with antisense morpholino or Endo-porter vehicle only. (E) Scatter plot of editing at the intronic editing hotspot 2
(position +262) in GluA2 pre-mRNA versus editing at the Q/R site with varying dose of antisense morpholino. The data points were tested for
correlation using Spearman’s rank.
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Morpholino oligos are typically used to disrupt splicing
by sterically blocking splice sites. For example, by
hybridizing to the donor splice site morpholinos prevent
base pairing of the U1 snRNA and thus assembly of the
spliceosome. The antisense target in our study is around
!290 nucleotides downstream of the donor splice site. In
addition, although the target and splice donor are on the
same helical element of the secondary structure, the
nearest end of the target is around 12 bp from the start
of the splice site. Furthermore, splicing occurs more
rapidly for Q/R edited pre-mRNA because editing and
splicing are co-ordinated by the C-terminal domain of
RNA polymerase II (41,49). As a consequence, binding
of a high-affinity antisense probe is less likely for the
edited pre-mRNA. Therefore, a direct effect of the anti-
sense on donor splice site recognition could be biased for
the unedited pre-mRNA and predict differences in the
IC50 for editing in pre-mRNA versus mRNA resulting in
dose-dependent deviations from the model described in
Supplementary Figure S6, which we do not observe
(Figure 5A and B). Together, it seems unlikely that the
antisense has a direct impact on splicing but rather exerts
a specific effect on editing.
In summary, this antisense approach should open up
in-depth characterization of other A-to-I editing sites.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–3 and Supplementary Figures
1–6.
Figure 6. Preferential splicing of Q/R-edited pre-mRNA prevents antisense inhibition in MIN-6 cells. (A) Example sequence chromatogram traces of
the Q/R site from pre-mRNA sequence amplified from cDNA. As the Q/R site is exclusively edited by Adar2, this indicates that SH-SY5Y and
MIN-6 have low-and high-editing activity, respectively. As with MIN-6, Adar2 editing activity in the brain is high. (B) A schematic illustration of the
Adar2 protein and the position of the mutations introduced by cloning to create inactive (E396A) and dominant-negative (EAA) EGFP-ADAR2
mutants. The amino terminal EGFP tag is not illustrated. The Adar2b protein is 711 amino acids in length. Adar2=adenosine deaminase acting on
RNA 2; NLS=nuclear localization signal; DD=deaminase domain. (C) Inhibition of Q/R editing in MIN-6 GluA2 is observed with Adar2
mutants (positive controls) and antisense morpholino. The negative control was empty vector. Restriction enzyme (TauI) digests were performed
on RT-PCR fragments amplified from pre-mRNA and loaded on an agarose gel (2%), which was then post-stained with ethidium bromide. The high
molecular weight corresponds to GluA2 unedited at the Q/R site. R=edited digestion fragment; Q=unedited digestion fragment. Cells were
transfected by electroporation. (D) Inhibition of endogenous editing can be detected as early as 12 h after antisense morpholino transfection.
Time course determination of changes in MIN-6 GluA2 pre-mRNA and mRNA editing at the Q/R site are shown for a single experiment. Data
points represent the percentage editing determined from the peak heights of sequence chromatograms. Examples of sequence traces from the 4-day
time point are shown on the right. Cells were transfected by electroporation. (E) Digestion of PCR product from MIN-6 cDNA and genomic DNA
with an enzyme (TauI) that recognizes the edited sequence (GCGGC) confirms that both genomic alleles encode a glutamine (Q) at the Q/R site.
A constitutive TauI restriction site in the amplicon incorporated by one of the primers served as a control for digestion. N=non-digested fragment;
R=edited digestion fragment; Q=unedited digestion fragment.
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Figure S1 
Antisense morpholino directed against the Q/R editing substrate is editing site specific. 
A. Experiment showing the effect of 10 µM standard negative control and Q/R-substrate antisense morpholino 
on the extent of editing in Q/R and R/G site minigene transcripts expressed in HeLa cells. Quantification of 
editing from peak heights is shown below the DNA sequence chromatograms. Editing inhibition is only seen in 
the antisense condition for the Q/R site.  We reproduced these findings in a separate experiment (R/G site 
editing: control = 9 %, n = 2; antisense = 9 %, n = 2).  
B. Experiment showing the effect of Q/R-substrate antisense morpholino on the extent of editing at site A of 
serotonin receptor 5-HT2C R mRNA endogenously expressed in SH-SY5Y cells. Quantification of editing from 
peak heights is shown below the DNA sequence chromatograms. No inhibition of editing was apparent in the 
antisense conditions (Site A editing: vehicle = 33 %, n = 2; 10 µM antisense = 37 %, n = 2), suggesting that 
editing site specificity was maintained for the experiments presented in Figs 3 and 4, at least upto a morpholino 
concentration of 10 µM. Neither the Adar1 specific site B nor the other editing sites of this gene (not shown) 






Controls for antisense morpholino directed against Q/R editing of minigene transcript expressed in HeLa cells.  
Experiment showing the extent of editing at the Q/R site in minigene transcripts expressed in HeLa cells under 
different conditions: Negative = No vehicle or morpholino; Vehicle = morpholino delivery reagent (Endoporter) 
only; Antisense =  Q/R-substrate targeted morpholino; Invert = morpholino like antisense but with inverted 
sequence; Mismatch = morpholino like antisense but with 5 mismatches. Editing inhibition is only seen in the 
antisense condition indicating that effect in the minigene reporter system was sequence-specific. Quantification 





Alternative steric antisense chemistry inhibits editing of the Q/R site in GluA2 mRNA endogenous to SH-
SY5Y.  
A. The chemical structure of a morpholino backbone. The shown structure is 4 bases in length and is depicted 
in what is equivalent to the 5’!3’ direction in nucleic acids. 
B. The chemical structure of a nucleic acid backbone. The shown structure is 4 bases in length in the 5’!3’ 
direction. To illustrate some common steric antisense modifications of the oligos, the 5’ sugar is exchanged for 
locked nucleic acid (LNA), and the 5’ internucleoside linkage is exchanged for N3’-P5’ phosphoramidate (NP). 
The alternative antisense oligo chemistry used in Figure S3 was a mixmer of 2’-O-Methyl and LNA sugar 
modifications with standard phosphodiester linkages. Chemical structures were created with Symyx Draw 3.1. 
The numbers of the ribose backbone are assigned according to IUPAC conventions. 
C. Dose-dependent inhibition of Q/R editing in SH-SY5Y GluR2 mRNA with a 2’-O-Me / LNA steric antisense 
oligo (see Figure S3B). The data points were fit with the equation a+b*ln(x+c) where a = 64.9, b = -6.27 and c 
= 0.141. Cells were transfected by electroporation. The sequence of the oligo is shown as an inset in the graph. 
Backbone sugars replaced with LNA are underlined in the sequence; the remaining ribose sugars had the 2’-O-








Selective splicing of edited GluA2 pre-mRNA is not observed for the R/G site in region CA1 microdissected 
from organotypic hippocampal slice. 
A. Note the concurrence of GluA2 R/G site editing state in pre-mRNA and spliced mRNA from the example 
DNA sequence chromatograms. Total RNA was harvested from microdissected CA1 subfield of a cultured 
hippocampal slice.  
B. Summary of replicate data for experiment shown in Fig S4A (n = 3). 
C. Summary of replicate data for a similar experiment but for the Q/R site (n = 3). Note that editing of the Q/R 
site in pre-mRNA is very high (95 % vs 100 % in mRNA), and thus the selective splicing of Q/R-edited 
transcripts is not readily apparent here. Compare with Fig 3A, where the bias is revealed in SH-SY5Y cells, 





Modest knockdown of Adar2 in neurons does not perturb Q/R editing state of GluA2 mRNA.  
Cultured hippocampal neurons were transfected with control siRNA (scrambled) and Adar2 siRNA. The GluA2 
Q/R site editing status of mRNA is virtually untouched. In contrast, a decrease in A-to-I editing is apparent for 
the GluA2 R/G site and the Adar2 specific GluK2 Y/C site (1). The decrease in R/G editing seen here with 
Adar2 knock-down is quantitively similar to that observed in CA1 after chronic activity-deprivation (2). 
Therefore, physiological changes in editing activity are unlikely to alter the Q/R editing status of protein 






Reaction scheme and proof of model used to fit data in figure 5B.  
In order to determine the relative splicing efficiency of edited and unedited pre-mRNAs we used the following 
simple model to fit our data. It can be shown that a plot of mRNA vs premRNA editing expressed as ratios will 
give a straight line with a slope equal to the ratio of the equilibrium constants for splicing of the edited and 
unedited premRNAs (K3/K1), which we will define here as the preferential splicing constant. When the ratios are 
converted to percentages the relationship between editing of mRNA vs premRNA becomes hyperbolic (see 
Figure 5B inset). Abbreviations: pU, pE, U and E correspond to unedited-premRNA, edited-premRNA, unedited-
mRNA and edited-mRNA respectively. K1, K2 and K3 are the equilibrium constants for the shown editing or 
splicing reaction steps. KT is the equilibrium constant of a non-real reaction step (dashed line arrow) shown here 
purely for illustration purposes.
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Supplemental Table 1. Details of sequence information relating to the in silico results presented in Figure 1  
!"#$%#&' ()**)+'+,*#' -&&#*./0'1'2,3,.,&#' 4)$,3%)+' ())56%+,3#&' 4#+738'
!"#"$%&'()*$ !"#$%& '()!*+& )!,-#-.-#/&0& 12342+3256123423413&789& *:;&
+&*$,-"./"01,)%$ <!=#>$%?//& )@ABC4D1D0& E<$FF-GH&'I*3:0+;D1& *41312:6*413240&789& *:;&
2"-(//&$."-(//&$."-(//&$ J-,=GG$& J-,'-,*D1& )!,-#-.-#/&0& 1:++11;:;61:++14**+&789& *:;&
+"*."$'1.#&)3%$&4)/(($ -,$%J"K$%& CCL'4& )!,-#-.-#/&0& 1:**1132561:**14413&789& *:;&
5"#&%63%$/)36".)*1%$ J=MM-%& NG/"1D5& E">/,<-%K=J&'I*;+4+4D1& 4*25;*;264*25;+:*&789& *:;&






9&//(,8-(:$;&6683%$ #$,#-./K& )RS$<<!".*D4D1& )!,-#-.-#/&*& *0;5+*+*6*0;5++01&7T9& *:;&
<&-%(3%$%1-(68,&$ K$,.=/,& K$,EP,1& E<$FF-GH&.<$FF-GHR235& 2203;62232+&789& *:;&
=,"/)#3-$.&-*),,(($ M".!M$MP& UK-'$,*& E<$FF-GH&'I3+*:50D1& 14042;;61404;:+&789& *:;&
7(6-"6)43%$#3-(*3%$ #-"./&G/#",& #=<B",1& '/%/.<$FF-GH&'/%/E<$FF-GHR102*& 14552;614504+&789& *:;&
<3'&(&$4)/&*.)-($ K,//.!/V& W(XXE@(XY& '/%/.<$FF-GH&'/%/E<$FF-GHR1++1& 04+:60:42&789& *25&
73%$#3%63/3%$ #-"./& '()#*3& )!,-#-.-#/&*& 35+5:2:3635+5:;*+&7T9& *+5&
>&,,3%$*"-?).(63%$ ,$K& ('E)*D0& )!,-#-.-#/&4& 1+443+32561+4433413&7T9& *:;&
9-(6),3/3%$.-(%)3%$ !$#.K/,& ),=',=R1D5& E<$FF-GH&Z@555454& 15**254615**3+5&7T9& *:;&
@('"0"#1%$"-0(($ O$%J$,--&,$K& H=>U,H1& '/%/.<$FF-GH&'/%/E<$FF-GHR4441& ::5*;6::05+&789& *:;&
9&?(&$'"-6)//3%$ J"=%/$&>=J& <$[C-,*& E<$FF-GH&.<$FF-GHR+& *434;+016*43*515:&7T9& *::&
A6,(0"#1%$
,-(0)6)#/(*)&,3%$
.\"=,,/G& .>/K,=4& E<$FF-GH&Z@*;**3:D1& *;14:036*;1*512&789& *:3&
=-16,"/&.3%$63*(63/3%$ ,$MM=K& -,P)"%4& )!,-#-.-#/&12& ::515::6::510*0&7T9& *:;&
=68","*&$'-(*6)'%$ >=O$& C=O$& E<$FF-GH&'/%/E<$FF-GHR1224& 315:06310*1&789& *:3&
BC33%$6&4&//3%$ !-,./& X\")$M4& )!,-#-.-#/&4& +:3;+++56+:3;31*+&7T9& *:;&
9&*(%$D&#(/(&-(%$ H-J& )$%]$#*D1& )!,-#-.-#/&12& 20:+4+53620:+*5+4&789& *:2&
E)/(%$6&,3%$ <$K& ]/G=.R<$K".R:D4& )!,-#-.-#/&^1& +1*022+:6+1*02;01&7T9& *::&
F(/3-"'"0&$#)/&*"/)36&$ >$%H$& $=GB/G1& E<$FF-GH&'I1;4::*D1& :**2146:**;5+&7T9& *::&
73%,)/&$'3,"-(3%$D3-"$ F/,,/K& B".C"K]",1D5& E<$FF-GH&'I3;+5::D1& 02:4+;*602:*12;&789& *:+&
G"-):$&-&*)3%$ .!,/V& )UBBUNRE@(XY1& '/%/.<$FF-GH&'/%/E<$FF-GHR4*24& ::34*6:+1;0&789& *+4&
B-(*&6)3%$)3-"'&)3%$ !/HJ/!-J& @X_'X@U'& '/%/.<$FF-GH&'/%/E<$FF-GHR43;4& ;+1156;+0++&789& *:3&
71",(%$/36(D3.3%$ M,-V%&M$K& BP-G"<4D5& E<$FF-GH&'I04;+:3& 431134:;643113:*0&7T9& *::&
+,)-"'3%$?&#'1-3%$ F,"=K&M$K& >K/`$#1& '/%/.<$FF-GH&'/%/E<$FF-GHR1134& 15;**1615;:;2&789& *:2&
H(63.*&$'&6"%$ $G>$<$& [=<C$<1& '/%/.<$FF-GH&'/%/E<$FF-GHR341& *0*;;+6*00*:0&789& *:3&
=?(%$&-()%$ .!//>& U[=a,=1& )!,-#-.-#/&1+& 003+;+1:60033553*&7T9& *:3&
G3%$%6-"D&$ >=J& E.<,-F$15D4& )!,-#-.-#/&3& 03400;:3603402*4;&789& *:4&
I"%$<&3-3%$ <-V& QB_*D1& )!,-#-.-#/&1+& 0435:*3460435:+0;&7T9& *:3&
J":"0"*,&$&D-(6&*&$ /G/>!$%K& G-baF,*& E">/,<-%K=J&.<$FF-GHR:1& 11*1+;*1611*13*43&7T9& *:3&
+-"6&?(&$6&')*%(%$ !P,$b& >,-)$>1& '/%/.<$FF-GH&'/%/E<$FF-GHR402+& :*0216:*31+&789& *:+&
B68(*"'%$,)/D&(-($ G/../,&!/HJ/!-J&K/%,/<& WXN(X)& '/%/.<$FF-GH&'/%/E<$FF-GHR435;& 1:*:1:61:*;30&789& *:;&
98"/")'3%$8"DD#&**($ .G-K!& <!-@-F1& '/%/.<$FF-GH&'/%/E<$FF-GHR4:4;& 33:;263;5:2&789& *+1&
7"*"0)/'8(%$0"#)%,(6&$ ->-.."#& ^(Ua_U2& )!,-#-.-#/&2& 11324115361132410+1&7T9& *:0&
G&-6"'8(/3%$8&--(%(($ K$.#$%=$%&H/[=G& _X`AI+D5& E<$FF-GH&'I3:0314D1& :12**6:13;0&7T9& *:4&
=-*(,8"-81*683%$&*&,(*3%$ >G$KP>".& UaNa2& )!,-#-.-#/&14& 104*4*;56104*4+2;&7T9& *+5&
98-1%)#1%$'(6,&$4)//(($ >$=%K/H&K",KG/& )!,C=<^/G*D5D1& E<$FF-GH&Z@230:;+D1& 0*1;02+60*1;34:&7T9& *+5&
+)/"0(%63%$%(*)*%(%$ .-FK.!/GG&K",KG/& C/GE=%R1D5& E<$FF-GH&Z@453252D1& 444+2246444+;41&789& *+5&
F*"/(%$6&-"/(*)*%(%$ G=?$,H& a%-)$,4D5& )!,-#-.-#/&2& 1433550**6143355+;+&7T9& *:2&
2&//3%$.&//3%$ <!=<O/%& YaE@Q)4& )!,-#-.-#/&0& 442:5+*06442:15;;&789& *::&
7)/)&.-(%$.&//"'&?"$ K",O/P& QB_4& )!,-#-.-#/&0& 452*53;6452*023&789& *+5&
F*&%$'/&,1-81*68"%$ H"<O& H"<O1& E<$FF-GH&.<$FF-GH02:& +3;3:06+;5401&789& *+3&
7)/"'%(,,&63%$3*03/&,3%$ M"HJ/,=J$,& B/GQ%H:D*& E<$FF-GH&Z@22:2;+D1& +320*4:6+320+53&7T9& *3*&
<&)*("'1.(&$.3,,&,&$ ?/M,$&F=%<!& K$/'"K*D4D0& )!,-#-.-#/&0& 4;4;+13164;4;+2::&789& *3:&
K)*"'3%$,-"'(6&/(%$ <G$V/H&F,-J& Z'AR0D4& E<$FF-GH&'I1+4+0:D1& *351516*350+*&789& *+*&
cJ&,(#)-(&$68&/3#*&)& <-/G$<$%K!& I$K)!$1& E<$FF-GH&Z@1*400:D1& 143;:612550&789& 415;&
cJ)'(%"%,)3%$"63/&,3%& J$,& I/>U<"1& )!,-#-.-#/&I'0& 453:10316453:1334&7T9& 054&
9&//"-8(*683%$#(/((& .!$,O& X.!$,O&1D0d& Y'E&aa`d515014**D1&& 1+4064102&7T9& 044&
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All sequence data was obtained via Ensembl (http://www.ensembl.org, accessed 05/08/2012) except shark sequence, 
which was from the IMBC elephant shark genome project: http://esharkgenome.imcb.a-star.edu.sg/. *Data from marked 
species were used only in Figure 1C for sequence comparison of Q/R site editing substrate. Nonetheless their inclusion in 
the alignment would give a similar secondary structure and results as that shown in Figure 1A and B. 
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Supplemental Table 2. Sequences of morpholino oligonucleotides used in this study. Small bold letters indicate the 
sequence at mismatch positions. 
 
Antisense 5’- ATG AGA ATA TGC AGC AAA AAC ACG G -3’ 
Control 5’- CCT CTT ACC TCA GTT ACA ATT TAT A -3’ 
Invert 5’- GGC ACA AAA ACG ACG TAT AAG AGT A -3’ 
Mismatch 5’- ATG AcA ATA TcC tGg AAA AAg ACG G -3’ 
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Supplemental Table 3. Comparison of % editing between region CA1 microdissected from organotypic 
hippocampal slice and the cell lines used in this study for some A-to-I editing sites in GluA2.  
 Hippocampal CA1 SH-SY5Y MIN-6 
pre-mRNA    
 Q/R 95 24 100 
 Hotspot 1    
    +60 54 8 35 
 Hotspot 2    
   +262 20 27 60 
   +263 46 5 59 
   +264 8 1 24 
 R/G 33 n.d n.d 
    
mRNA    
  Q/R 100 84 100 
  R/G 31 n.d. 75 
 
Note the extent of editing at these sites in MIN-6 is more like that observed in whole brain extract (see (1). n.d. not 
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